| Open Document File Size: 568,02 KBShare Result on Facebook
Company IgG / Page / Dendreon Corporation / / Country United States / / Event FDA Phase / / Facility NH2 terminus / COOH terminus / / IndustryTerm autologous human product / chemical androgen blockade / physiological solution / leukapheresis product / qPCR-quantitative polymerase chain / autologous active cellular immunotherapy product / clinical product / / MedicalCondition tumor / metastatic prostate cancer / Cancer / disease / urinary retention / epidural metastases / metastatic androgen-independent prostate cancer / prostate cancers / non-dermatologic cancer / receptor negative thymoma / progressive metastatic prostate cancer / J Cancer / prostatic adenocarcinoma / independent prostate cancer / Prostate Specific Inflammation / Refractory Prostate Cancer / INTRODUCTION Prostate cancer / EL4-hHER2 tumor / prostate cancer / hormone-refractory prostate cancer / neurologic symptoms / androgen-independent hormone-refractory prostate cancer / tissue-specific autoimmune prostatitis / / MedicalTreatment Immunization / leukapheresis / hormonal therapy / immunizations / vaccination / chemotherapy / intravenous infusion / immunotherapy / / Organization Tissue and Gene Therapies Division of Clinical Evaluation / FOOD AND DRUG ADMINISTRATION Center / Biologics Evaluation and Research Office / / Person Yongjie Zhou / Van Parijs / Mark Davidson / Mercedes Serabian / Ann Oncol / D. Lori Tull / M.D. Celia Witten / Ashok Batra / / Position DIVISION DIRECTOR / PHARM/TOX SUPERVISOR / OFFICE DIRECTOR / / Product potassium chloride / calcium chloride / prednisone / sodium lactate / APC8015 / / PublishedMedium Nature Biotechnology / / Technology cell Receptors / antibodies / Biotechnology / chemotherapy / /
SocialTag |
Pharmacology Toxicology Review - Provenge